Atrys Health (Spain) Performance
| ATRY Stock | EUR 3.09 0.05 1.59% |
The firm shows a Beta (market volatility) of 0.0927, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Atrys Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Atrys Health is expected to be smaller as well. At this point, Atrys Health SL has a negative expected return of -0.12%. Please make sure to confirm Atrys Health's total risk alpha, maximum drawdown, skewness, as well as the relationship between the treynor ratio and potential upside , to decide if Atrys Health SL performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Atrys Health SL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
| Begin Period Cash Flow | 17.5 M | |
| Total Cashflows From Investing Activities | -2.4 M |
Atrys |
Atrys Health Relative Risk vs. Return Landscape
If you would invest 342.00 in Atrys Health SL on August 31, 2024 and sell it today you would lose (28.00) from holding Atrys Health SL or give up 8.19% of portfolio value over 90 days. Atrys Health SL is generating negative expected returns and assumes 1.7387% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Atrys, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Atrys Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atrys Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Atrys Health SL, and traders can use it to determine the average amount a Atrys Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0682
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATRY |
Estimated Market Risk
| 1.74 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Atrys Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atrys Health by adding Atrys Health to a well-diversified portfolio.
Atrys Health Fundamentals Growth
Atrys Stock prices reflect investors' perceptions of the future prospects and financial health of Atrys Health, and Atrys Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Atrys Stock performance.
| Return On Equity | -0.0723 | |||
| Return On Asset | 0.0022 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 647.57 M | |||
| Shares Outstanding | 75.89 M | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 2.47 X | |||
| Revenue | 121.01 M | |||
| EBITDA | 6.88 M | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 146.81 M | |||
| Debt To Equity | 0.95 % | |||
| Book Value Per Share | 4.67 X | |||
| Cash Flow From Operations | 4.69 M | |||
| Earnings Per Share | (0.46) X | |||
| Total Asset | 565.63 M | |||
About Atrys Health Performance
By analyzing Atrys Health's fundamental ratios, stakeholders can gain valuable insights into Atrys Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Atrys Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Atrys Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 525 people.Things to note about Atrys Health SL performance evaluation
Checking the ongoing alerts about Atrys Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Atrys Health SL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Atrys Health SL generated a negative expected return over the last 90 days | |
| Atrys Health SL has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 121.01 M. Net Loss for the year was (23.25 M) with profit before overhead, payroll, taxes, and interest of 27.78 M. | |
| About 78.0% of the company shares are held by company insiders |
- Analyzing Atrys Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Atrys Health's stock is overvalued or undervalued compared to its peers.
- Examining Atrys Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Atrys Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Atrys Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Atrys Health's stock. These opinions can provide insight into Atrys Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Atrys Stock analysis
When running Atrys Health's price analysis, check to measure Atrys Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atrys Health is operating at the current time. Most of Atrys Health's value examination focuses on studying past and present price action to predict the probability of Atrys Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atrys Health's price. Additionally, you may evaluate how the addition of Atrys Health to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |